{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T11:00:34Z","timestamp":1793703634742,"version":"4.5.1"},"reference-count":58,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1097\/mjt.0b013e3181df8df5","type":"journal-article","created":{"date-parts":[[2010,6,9]],"date-time":"2010-06-09T06:59:48Z","timestamp":1276066788000},"page":"e202-e208","source":"Crossref","is-referenced-by-count":32,"title":["Hepatic Fibrosis and the Renin-Angiotensin System"],"prefix":"10.1097","volume":"18","author":[{"given":"Ghulam","family":"Abbas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina G","family":"Silveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith D","family":"Lindor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-11-20210202","first-page":"1","article-title":"Deaths: preliminary data for 2002.","volume":"52","author":"Kochanek","year":"2004","journal-title":"Natl Vital Stat Rep"},{"key":"R2-11-20210202","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.jhep.2006.10.018","article-title":"The renin-angiotensin system in a rat model of hepatic fibrosis: evidence for a protective role of Angiotensin-(1-7).","volume":"46","author":"Pereira","year":"2007","journal-title":"J Hepatol"},{"key":"R4-11-20210202","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1471-4892(02)00144-3","article-title":"Therapeutic strategies to halt renal fibrosis.","volume":"2","author":"Yu","year":"2002","journal-title":"Curr Opin Pharmacol"},{"key":"R5-11-20210202","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1089\/ars.2005.7.1346","article-title":"Liver fibrogenesis: a new role for the renin-angiotensin system.","volume":"7","author":"Bataller","year":"2005","journal-title":"Antioxid Redox Signal"},{"key":"R6-11-20210202","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0016-5085(00)70368-4","article-title":"Angiotensin II induces contraction and proliferation of human hepatic stellate cells.","volume":"118","author":"Bataller","year":"2000","journal-title":"Gastroenterology"},{"key":"R7-11-20210202","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1002\/hep.20665","article-title":"Systemic infusion of angiotensin II exacerbates liver fibrosis in bile duct-ligated rats.","volume":"41","author":"Bataller","year":"2005","journal-title":"Hepatology"},{"key":"R8-11-20210202","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0168-8278(02)00307-0","article-title":"Hemodynamic and antifibrotic effects of losartan in rats with liver fibrosis and\/or portal hypertension.","volume":"37","author":"Croquet","year":"2002","journal-title":"J Hepatol"},{"key":"R9-11-20210202","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1053\/gast.2001.25480","article-title":"Angiotensin-converting enzyme inhibition attenuates the progression of rat hepatic fibrosis.","volume":"121","author":"Jonsson","year":"2001","journal-title":"Gastroenterology"},{"key":"R10-11-20210202","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/sj.bjp.0705339","article-title":"An angiotensin II type 1 receptor antagonist, olmesartan medoxomil, improves experimental liver fibrosis by suppression of proliferation and collagen synthesis in activated hepatic stellate cells.","volume":"139","author":"Kurikawa","year":"2003","journal-title":"Br J Pharmacol"},{"key":"R11-11-20210202","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1053\/jhep.2002.32679","article-title":"Effect of angiotensin receptor antagonist on liver fibrosis in early stages of chronic hepatitis C.","volume":"36","author":"Terui","year":"2002","journal-title":"Hepatology"},{"key":"R12-11-20210202","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1097\/01.TP.0000128913.09774.CE","article-title":"Beneficial effect of angiotensin-blocking agents on graft fibrosis in hepatitis C recurrence after liver transplantation.","volume":"78","author":"Rimola","year":"2004","journal-title":"Transplantation"},{"key":"R13-11-20210202","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/hep.510290203","article-title":"Effect of losartan, an angiotensin II receptor antagonist, on portal pressure in cirrhosis.","volume":"29","author":"Schneider","year":"1999","journal-title":"Hepatology"},{"key":"R14-11-20210202","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1002\/hep.20420","article-title":"Therapeutic efficacy of an angiotensin II receptor antagonist in patients with nonalcoholic steatohepatitis.","volume":"40","author":"Yokohama","year":"2004","journal-title":"Hepatology"},{"key":"R15-11-20210202","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.jhep.2007.01.017","article-title":"AT1 receptor antagonist Candesartan in selected cirrhotic patients: effect on portal pressure and liver fibrosis markers.","volume":"46","author":"Debernardi-Venon","year":"2007","journal-title":"J Hepatol"},{"key":"R16-11-20210202","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/j.1478-3231.2009.01973.x","article-title":"The effect of angiotensin-blocking agents on liver fibrosis in patients with hepatitis C.","volume":"29","author":"Corey","year":"2009","journal-title":"Liver Int"},{"key":"R17-11-20210202","doi-asserted-by":"crossref","first-page":"7560","DOI":"10.3748\/wjg.v11.i48.7560","article-title":"Effects of six months losartan administration on liver fibrosis in chronic hepatitis C patients: a pilot study.","volume":"11","author":"Sookoian","year":"2005","journal-title":"World J Gastroenterol"},{"key":"R18-11-20210202","first-page":"171","article-title":"Clinical usefulness of the angiotensin II receptor antagonist losartan in patients with portal hypertensive gastropathy.","volume":"53","author":"Wagatsuma","year":"2006","journal-title":"Hepatogastroenterology"},{"key":"R19-11-20210202","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.2337\/dc06-0570","article-title":"Efficacy and safety of angiotensin II receptor blockade in elderly patients with diabetes.","volume":"29","author":"Winkelmayer","year":"2006","journal-title":"Diabetes Care"},{"key":"R20-11-20210202","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1055\/s-2007-1007295","article-title":"Hepatorenal disorders: role of the renin-angiotensin-aldosterone system.","volume":"14","author":"Bernardi","year":"1994","journal-title":"Semin Liver Dis"},{"key":"R21-11-20210202","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0168-8278(01)00146-5","article-title":"Effect of angiotensin II type 1 receptor blockade on experimental hepatic fibrogenesis.","volume":"35","author":"Paizis","year":"2001","journal-title":"J Hepatol"},{"key":"R22-11-20210202","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0163-7258(01)00124-3","article-title":"The hyperdynamic circulation in cirrhosis: an overview.","volume":"89","author":"Blendis","year":"2001","journal-title":"Pharmacol Ther"},{"key":"R23-11-20210202","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S1386-6346(02)00306-6","article-title":"Angiotensin II stimulates the nuclear translocation of Smad2 and induces PAI-1 mRNA in rat hepatic stellate cells.","volume":"25","author":"Kamada","year":"2003","journal-title":"Hepatol Res"},{"key":"R24-11-20210202","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1111\/j.1440-1746.2006.04735.x","article-title":"Rho\/Rho kinase is a key enzyme system involved in the angiotensin II signaling pathway of liver fibrosis and steatosis.","volume":"22","author":"Kitamura","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"key":"R25-11-20210202","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.abb.2007.04.016","article-title":"NOX in liver fibrosis.","volume":"462","author":"De Minicis","year":"2007","journal-title":"Arch Biochem Biophys"},{"key":"R26-11-20210202","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1172\/JCI18212","article-title":"NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis.","volume":"112","author":"Bataller","year":"2003","journal-title":"J Clin Invest"},{"key":"R29-11-20210202","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0168-8278(02)00104-6","article-title":"Inhibition of renin-angiotensin system attenuates liver enzyme-altered preneoplastic lesions and fibrosis development in rats.","volume":"37","author":"Yoshiji","year":"2002","journal-title":"J Hepatol"},{"key":"R30-11-20210202","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","article-title":"Liver fibrosis.","volume":"115","author":"Bataller","year":"2005","journal-title":"J Clin Invest"},{"key":"R31-11-20210202","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1053\/jhep.2003.50127","article-title":"Genetic polymorphisms and the progression of liver fibrosis: a critical appraisal.","volume":"37","author":"Bataller","year":"2003","journal-title":"Hepatology"},{"key":"R32-11-20210202","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1161\/01.RES.31.3.356","article-title":"Purification and properties of angiotensin-converting enzyme from hog lung.","volume":"31","author":"Dorer","year":"1972","journal-title":"Circ Res"},{"key":"R33-11-20210202","first-page":"42","article-title":"Biochemistry and kinetics of the renin-angiotensin system.","volume":"26","author":"Skeggs","year":"1967","journal-title":"Fed Proc"},{"key":"R34-11-20210202","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1440-1681.1992.tb02802.x","article-title":"The tissue renin-angiotensin system and its functional role.","volume":"19","author":"Johnston","year":"1992","journal-title":"Clin Exp Pharmacol Physiol Suppl"},{"key":"R35-11-20210202","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0016-5085(03)00695-4","article-title":"Activated human hepatic stellate cells express the renin-angiotensin system and synthesize angiotensin II.","volume":"125","author":"Bataller","year":"2003","journal-title":"Gastroenterology"},{"key":"R36-11-20210202","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1053\/gast.2002.36561","article-title":"Up-regulation of components of the renin-angiotensin system in the bile duct-ligated rat liver.","volume":"123","author":"Paizis","year":"2002","journal-title":"Gastroenterology"},{"key":"R37-11-20210202","doi-asserted-by":"crossref","first-page":"402","DOI":"10.2169\/internalmedicine1962.30.402","article-title":"Diagnostic significance of serum angiotensin-converting enzyme activity in biochemical tests with special reference of chronic liver diseases.","volume":"30","author":"Sakata","year":"1991","journal-title":"Jpn J Med"},{"key":"R38-11-20210202","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1210\/endo-105-3-796","article-title":"Localization of angiotensinogen in rat liver by immunocytochemistry.","volume":"105","author":"Morris","year":"1979","journal-title":"Endocrinology"},{"key":"R40-11-20210202","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1053\/jhep.2001.28231","article-title":"Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats.","volume":"34","author":"Yoshiji","year":"2001","journal-title":"Hepatology"},{"key":"R41-11-20210202","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0006-291X(03)01357-3","article-title":"AT1A-deficient mice show less severe progression of liver fibrosis induced by CCl(4).","volume":"308","author":"Kanno","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"R42-11-20210202","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jhep.2005.02.034","article-title":"Attenuated hepatic inflammation and fibrosis in angiotensin type 1a receptor deficient mice.","volume":"43","author":"Yang","year":"2005","journal-title":"J Hepatol"},{"key":"R43-11-20210202","doi-asserted-by":"crossref","first-page":"G642","DOI":"10.1152\/ajpgi.00037.2003","article-title":"Prolonged infusion of angiotensin II into normal rats induces stellate cell activation and proinflammatory events in liver.","volume":"285","author":"Bataller","year":"2003","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"R44-11-20210202","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1042\/BJ20040634","article-title":"Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism.","volume":"383","author":"Rice","year":"2004","journal-title":"Biochem J"},{"key":"R45-11-20210202","doi-asserted-by":"crossref","first-page":"14838","DOI":"10.1074\/jbc.M200581200","article-title":"Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase.","volume":"277","author":"Vickers","year":"2002","journal-title":"J Biol Chem"},{"key":"R46-11-20210202","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.tem.2004.03.001","article-title":"ACE2, a new regulator of the renin-angiotensin system.","volume":"15","author":"Burrell","year":"2004","journal-title":"Trends Endocrinol Metab"},{"key":"R47-11-20210202","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1113\/expphysiol.2005.031096","article-title":"Protection from angiotensin II-induced cardiac hypertrophy and fibrosis by systemic lentiviral delivery of ACE2 in rats.","volume":"90","author":"Huentelman","year":"2005","journal-title":"Exp Physiol"},{"key":"R48-11-20210202","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1152\/physiolgenomics.00312.2005","article-title":"ACE2 gene transfer attenuates hypertension-linked pathophysiological changes in the SHR.","volume":"27","author":"Diez-Freire","year":"2006","journal-title":"Physiol Genomics"},{"key":"R49-11-20210202","doi-asserted-by":"crossref","first-page":"H736","DOI":"10.1152\/ajpheart.00937.2006","article-title":"Prevention of angiotensin II-induced cardiac remodeling by angiotensin-(1-7).","volume":"292","author":"Grobe","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R50-11-20210202","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1053\/gast.2002.33367","article-title":"Reversibility of liver fibrosis and cirrhosis following treatment for hepatitis C.","volume":"122","author":"Arthur","year":"2002","journal-title":"Gastroenterology"},{"key":"R51-11-20210202","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1053\/j.gastro.2004.03.009","article-title":"Spontaneous recovery from micronodular cirrhosis: evidence for incomplete resolution associated with matrix cross-linking.","volume":"126","author":"Issa","year":"2004","journal-title":"Gastroenterology"},{"key":"R52-11-20210202","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1055\/s-2001-17558","article-title":"Hepatic stellate cells as a target for the treatment of liver fibrosis.","volume":"21","author":"Bataller","year":"2001","journal-title":"Semin Liver Dis"},{"key":"R53-11-20210202","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/hep.23104","article-title":"Angiotensin-converting-enzyme 2 inhibits liver fibrosis in mice.","volume":"50","author":"Osterreicher","year":"2009","journal-title":"Hepatology"},{"key":"R55-11-20210202","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/oby.2007.114","article-title":"ACE inhibition and AT1 receptor blockade prevent fatty liver and fibrosis in obese Zucker rats.","volume":"16","author":"Toblli","year":"2008","journal-title":"Obesity (Silver Spring)"},{"key":"R56-11-20210202","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1386-6346(01)00102-4","article-title":"Anti-fibrogenic effect of an angiotensin converting enzyme inhibitor on chronic carbon tetrachloride-induced hepatic fibrosis in rats.","volume":"21","author":"Ohishi","year":"2001","journal-title":"Hepatol Res"},{"key":"R57-11-20210202","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1111\/j.1440-1746.2006.04331.x","article-title":"Effects of perindopril and valsartan on expression of transforming growth factor-beta-Smads in experimental hepatic fibrosis in rats.","volume":"21","author":"Xu","year":"2006","journal-title":"J Gastroenterol Hepatol"},{"key":"R58-11-20210202","first-page":"159","article-title":"Anti-fibrogenic effects of captopril and candesartan cilexetil on the hepatic fibrosis development in rat. The effect of AT1-R blocker on the hepatic fibrosis.","volume":"55","author":"Tuncer","year":"2003","journal-title":"Exp Toxicol Pathol"},{"key":"R59-11-20210202","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s10620-007-9941-y","article-title":"Effect of angiotensin-converting enzyme inhibition on experimental hepatic fibrogenesis.","volume":"53","author":"Turkay","year":"2008","journal-title":"Dig Dis Sci"},{"key":"R60-11-20210202","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.3748\/wjg.15.2512","article-title":"Relationship between angiotensin-(1-7) and angiotensin II correlates with hemodynamic changes in human liver cirrhosis.","volume":"15","author":"Vilas-Boas","year":"2009","journal-title":"World J Gastroenterol"},{"key":"R61-11-20210202","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0168-8278(03)00459-8","article-title":"Pro-fibrotic polymorphisms predictive of advanced liver fibrosis in the severely obese.","volume":"39","author":"Dixon","year":"2003","journal-title":"J Hepatol"},{"key":"R62-11-20210202","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1053\/he.2000.6253","article-title":"Host genetic factors influence disease progression in chronic hepatitis C.","volume":"31","author":"Powell","year":"2000","journal-title":"Hepatology"},{"key":"R63-11-20210202","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0002-9343(02)01241-X","article-title":"Vascular and cardiac benefits of angiotensin receptor blockers.","volume":"113","author":"Schiffrin","year":"2002","journal-title":"Am J Med"}],"container-title":["American Journal of Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00045391-201111000-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:22:36Z","timestamp":1786040556000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00045391-201111000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":58,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/mjt.0b013e3181df8df5","relation":{},"ISSN":["1075-2765"],"issn-type":[{"value":"1075-2765","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}